Navigation Links
BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
Date:11/6/2007

FREDERICK, Md., Nov. 6 /PRNewswire-FirstCall/ -- BioElectronics Corporation, (Pink Sheets: BIEL), announced today that Michael Seidenman, R. Ph. has joined the company's management as Vice President of Sales.

Mr. Seidenman is a licensed pharmacist, a surgical appliance technician, and is well versed in electro medicine devices. He brings to the company twenty five years experience in medical device sales management. Mr. Seidenman has launched many new products, developed and managed independent sales agent organizations, established and managed wholesale distributors, and sold and established national accounts. As a consultant he has evaluated, established, and trained national sales forces.

"We are very pleased to have Mike join our management team. We know that his extensive experience and knowledge base will be a driving force for the company's sales. We are sure that he will have an innovative approach to broadening our current approach to marketing and selling the healing benefits of ActiPatch," said Andrew Whelan, President of BioElectronics.

BioElectronics Corporation is the maker of ActiPatch(TM). ActiPatch is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for a few cents per hour. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.

For more information visit http://www.bioelectronicscorp.com

Safe Harbor Statement:

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of f
'/>"/>

SOURCE BioElectronics Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. BioElectronics Corporation Receives 2007 Economic Development Innovator of the Year Award
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. Brooke Franchise Corporation Announces Selected July Results
4. MedThink Communications Retained by NanoBio Corporation
5. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
6. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
7. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
8. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
9. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
10. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
11. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...UILLY-SUR-SEINE,France,Nov.27/PRNewswire/--TeamGar...teamdedicatedtoethicalsportinganddevelopingthenext...illbecomeTeamGarmin-TransitionswiththeadditionofTr...Opticalistheworld,sleadingmanufacturerofadaptiveey...yinthewidestselectionofspectaclelensessuchasTransi...
(Date:11/27/2009)...tes to bring unprecedented medical, economic burde...HealthDay News) -- The number of people with diabe...r the next 25 years, a new study predicts. , Th...lion people with the disease, up from 23.7 million...ng people with diabetes will triple, the study als...
(Date:11/27/2009)... Specialist manufacturers who use m...re saving millions of dollars by bringing in techn... Increasing numbers of pro-active medical manufact...the concept stage of their projects, ensuring that...gn processes or potentially outdated technology. ...
(Date:11/26/2009)...ext 25 years, the number of Americans living with ...million in 2009 to 44.1 million in 2034. Over the ...le, rising from $113 billion to $336 billion, even...searchers based at the University of Chicago repor...e number of those with diabetes covered by Medicar...
(Date:11/26/2009)... No more letters from the North Pol...ized text messages from Santa , ...ncrease operational efficiencies at the North Pole...keep children all over the globe informed of his C...Santa’s research department have identified ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
... NCCN names Cold Spring Publishing, LLC, as the ne...e National Comprehensive Cancer Network. Cold Spri... company led by Jack Gentile, founder of PRR, Inc....y(TM). , , FORT WASHINGTON, Pa., Feb. 10 JNCCN ...
...China, Feb. 10 /PRNewswire-Asia-FirstCall/ -- Chin...r ,the Company,) (Nasdaq: CSKI ), a,leading full...-the-counter,drugs in the People,s Republic of Chi...ibution from its recent,acquisitions, the Company ...
...led 2.7 million prescriptions through AZ&Me(TM...el., Feb. 10 AstraZeneca (NYSE: AZN ) announc...s to 440,541 patients in the United States last ye...neca is committed to helping patients who are faci...
...b. 10 HMS (Nasdaq: HMSY ) today announced that ...m Neighborhood Health Providers and Optima Health,... lives to its managed care portfolio. HMS will pro...coverage not previously known for its Medicaid mem...
...ems to reduce the risk of cognitive impairment, de...s) -- Chalk up another endorsement for the so-call...s rich in fruits, vegetables, fish and olive oil, ... -- marked by forgetfulness and difficulty concent...
...Calif., Feb. 10 Firefighter and wife help others ... Veteran firefighter Bryan Russell, from the "OC,"...nnifer found the hero in her life when she met fir...e asks, "Do you know any single people?" In Jenn a...
Other Medicine News:Health News:JNCCN Names New Publishing Company 2Health News:JNCCN Names New Publishing Company 3Health News:China Sky One Medical, Inc. Reaffirms Guidance for 2008 Revenue and Net Income and Provides Business Update 2Health News:China Sky One Medical, Inc. Reaffirms Guidance for 2008 Revenue and Net Income and Provides Business Update 3Health News:AstraZeneca Helped More Than 440,000 Patients Save $612 Million on Medicines in 2008 2Health News:HMS Awarded New Contracts for Managed Care Services 2Health News:Mediterranean Diet Aids the Aging Brain: Study 2Health News:Mediterranean Diet Aids the Aging Brain: Study 3Health News:Heroes Find Love, Love Finds Heroes 2
(Date:11/27/2009)...LTLAKECITY,Nov.27/PRNewswire-FirstCall/--Booth-364...,apremiersupplierofX-raytubesandflatpaneldigitalim...heRSNAAnnualMeetinginChicago,Ill.fromNovember29-De...chnologyformultiplemodalitiesaswellasspecializedca...llshowcasethelatestX-raytechnologyincluding: ,,...
(Date:11/25/2009)...NOGAPARK,Calif.,Nov.25/PRNewswire/--PraxisElectron...ricanAcademyofFamilyPhysicians,(AAFP)FamilyPractic...provingmedicalquality,healthmaintenance,anddisease...n.Praxisalsoranked#1amongdoctorsindicatingtheirEMR...,Praxisalsorankednumberoneinthecountryinprovidinge...
(Date:11/25/2009)...INCETON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharmas...alcompanycommittedtodiscovering,developingandcomme...dfinancialresultsforthefiscalyearendedSeptember30,...ncash,cashequivalentsandshortterminvestments. ,... ,, Phase2bTrial ,, InlateNovember2009,a...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Scientists Spot Clue to Cancers Aggressiveness 56441 1Lapatinib shows minimal effect against liver cancer 56439 1Lapatinib shows minimal effect against liver cancer 56439 2Lapatinib shows minimal effect against liver cancer 56439 3Team reveals molecular mechanism underlying a form of diabetes 56437 1Team reveals molecular mechanism underlying a form of diabetes 56437 2
...armaceuticals, a privately-held biopharmaceutical ...ollment in the Company,s second pivotal Phase 3 cl... Together with the previously completed first pivo... fully enrolled its planned pivotal Phase 3 studie...e oral therapy currently in development for the tr...
...ut tumor growth and reduced the risk of disease pr... , - Only once-daily oral cancer treatment to dire...ontrols tumor cell division and blood vessel growt...ntial of Afinitor in multiple additional cancers ,...ed today that Afinitor(R) (everolimus) tablets has...
Other Medicine Technology:QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 2QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 3Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 2Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 3Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 4Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 5Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 6Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 7Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 8
Urocare® Latex Urinary Leg Bag - Short-Wide
Urocare® Latex Urinary Leg Bag - Large
Medtronic Resting Heart™ System
DLP Recirculation Adapter, Y-Type
Medicine Products: